期刊文献+

D-二聚体对肝硬化门静脉血栓形成的预测价值 被引量:10

原文传递
导出
摘要 肝硬化合并门静脉血栓(portal vein thrombosis,PVT)者易出现顽固性腹水、上消化道大出血和小肠缺血坏死,严重威胁患者生命。D-二聚体是交联纤维蛋白降解过程中产生的复合物,是证实体内存在继发性纤溶和血栓形成的特异性指标,肝硬化患者D-二聚体通常较正常升高,特别在严重肝病时。本文通过观察肝硬化伴或不伴PVT患者D-二聚体变化,研究其作为肝硬化伴PVT形成预测指标的价值。
出处 《中华消化杂志》 CAS CSCD 北大核心 2008年第10期708-709,共2页 Chinese Journal of Digestion
  • 相关文献

参考文献9

  • 1中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 3Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review. Am J Gastroenterol,2002,97 : 535-541.
  • 4Gaiani S, Bolondi L, Li Bassi S, et al. Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology, 1991,100: 160-167.
  • 5Violi F, Ferro D, Basili S, et al. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. BMJ, 1994,309: 239-240.
  • 6Amitrano L, Brancaceio V, Guardascione MA, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology,2000,31 : 345-348.
  • 7Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol,2004,40: 736-741.
  • 8Mangia A, Villani MR, Cappucci G, et al. Causes of portal venous thrombosis in cirrhotic patients., the role of genetic and acquired factors. Eur J Gastroenterol Hepatol, 2005, 17: 745-751.
  • 9Wells PS, Anderson DR, Rodger M, et al. Evaluation of D dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med, 2003,349: 1227-1235.

二级参考文献15

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
  • 3Sanyal AJ.American Gastroenterological Association technical review on nonalcoholic fatty liver disease.Gastroenterology,2002,123:1705-1725.
  • 4Graif M,Yanuka M,Baraz M,et al.Quantitative estimation of attenuation in ultrasound video images:correlation with histology in diffuse liver disease.Invest Radiol,2000,35:319-324.
  • 5Ataseven H,Yildrim MH,Yalniz M,et al.Correlation between computerized tomographic findings and histopathologic grade/stage in non-alcoholic steatohepatitis.J Hepatol,2003,38(Suppl 2):A4177.
  • 6Farrell GC,George J,Pauline de la M.Hall,et al,eds.Fatty liver diseas:NASH and related disorders.Oxford:Blackwell Publishing,2005.159-207.
  • 7McCullough AJ,O'Connor JF.Alcoholic liver disease:proposed recommendations for the American College of Gastroenterology.Am J Gastroenterol,1998,93:2022-2036.
  • 8Stickel F,Hoehn B,Schuppan D,et al.Review article:Nutritional therapy in alcoholic liver disease.Aliment Pharmacol Ther,2003,18:357-373.
  • 9Mathurin P,Mendenhall CL,Carithers RLJr,et al.Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH):individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.J Hepatol,2002,36:480-487.
  • 10Imperiale TF,O'Connor JB,McCullough AJ.Corticosteroids are effective in patients with severe alcoholic hepatitis.Am J Gastroenterol,1999,94:3066-3068.

共引文献14249

同被引文献99

引证文献10

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部